Search

everythinglearnresearchcommunity

for

Search:↓

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

Patients with the same vitamin D receptor mutation showed different symptoms due to other factors.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

The document discusses various skin disorders and new therapeutic approaches.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

Four-amino acid part makes enzyme sensitive to finasteride.

A child with a rare type of rickets showed some improvement with high doses of vitamin D, but such conditions often respond poorly to treatment.

The new gel effectively treats psoriasis with minimal side effects.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

The new gel formulation for Acitretin improves topical delivery and reduces oral toxicity.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

MK-386 reduces sebum DHT levels.

The ointment is a safe, effective, and well-tolerated treatment for certain types of psoriasis.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Ritlecitinib works well and is safe for treating alopecia areata.

TAK-279 effectively reduces psoriasis symptoms and is safe.

DPR can show different hair characteristics, as seen in two brothers with normal hair.

The research helps understand how finasteride works and aids drug development.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.